Historique
Bulletin de Périodique
Addiction , Vol.106, n°11 - November 2011
Paru le :
24/10/2011
Article en page(s) :
1883-2052
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
• Editorial: Russia and human immunodeficiency virus- beyond crime and punishment. Samet J.H., p. 1883-1885.
• FOR DEBATE: Basing drug scheduling decisions on scientific ranking of harmfulness: false promise from false premises. Caulkins J.P., Reuter P., Coulson C., p. 1886-1890.
COMMENTARIES:
• Nutt et al.'s harm scales for drugs-room for improvement but better policy based on science with limitations than no science at all. Fischer B., Kendall P., p. 1891-1892.
• Let not the best be the enemy of the good. Nutt D., p. 1892-1893.
• Can harm ratings be useful? Rossow I., p. 1893-1894.
• Improved ranking of drugs on harmfulness can bring sense and order to a failed system. Obot I.S., p. 1894-1895.
• Scales and blinkers, motes and beams - whose view is obstructed on drug scheduling? Room R., p. 1895-1896.
• Response to commentaries. Caulkins J.P., Reuter P., Coulson C., p. 1896-1898.
• What can we learn from the Dutch cannabis coffeeshop system? Maccoun R.J., p. 1899-1910.
• A systematic review of methamphetamine precursor regulations. McKetin R., Sutherland R., Bright D.A., Norberg M.M., p. 1911-1924.
• Housewife or working mum-each to her own? The relevance of societal factors in the association between social roles and alcohol use among mothers in 16 industrialized countries. Kuntsche S., Knibbe R.A., Kuntsche E., Gmel G., p. 1925-1932.
• Commentary on Kuntsche et al. (2011): Mothers and bottles - the role of gender norms in shaping drinking. Armstrong E.M., p. 1933-1934.
• DSM-IV to DSM-5: the impact of proposed revisions on diagnosis of alcohol use disorders. Agrawal A., Heath A.C., Lynskey M.T., p. 1935-1943.
• Commentary on Agrawal et al. (2011): Assessing the impact of changes to diagnostic criteria on the estimated prevalence of alcohol use disorders in general population surveys. Slade T., Teesson M., Carragher N., Farrell M., p. 1944-1945.
• Drinking behaviour among men and women in China: the 2007 China Chronic Disease and Risk Factor Surveillance. Li Y., Jiang Y., Zhang M., Yin P., Wu F., Zhao W., p. 1946-1956.
• The role of alcohol in the Russian mortality crisis. Norstrom T., p. 1957-1965.
• The effect of neighborhood deprivation and residential relocation on long-term injection cessation among injection drug users (IDUs) in Baltimore, Maryland. Genberg B.L., Gange S.J., Go V.F., Celentano D.D., Kirk G.D., Latkin C.A., et al., p. 1966-1974.
• Commentary on Genberg et al. (2011): The structural vulnerability imposed by hypersegregated US inner-city neighborhoods - a theoretical and practical challenge for substance abuse research. Bourgois P., Hart L.K., p. 1975-1977.
• The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Turner K.M., Hutchinson S., Vickerman P., Hope V., Craine N., Palmateer N., et al., p. 1978-1988.
• Commentary on Turner et al. (2011): Significant global scale-up of harm reduction interventions and pragmatic research approaches needed to prevent hepatitis C transmission. Day C., Topp L., p. 1989-1990.
• Mephedrone: use, subjective effects and health risks. Winstock A., Mitcheson L., Ramsey J., Davies S., Puchnarewicz M., Marsden J., p. 1991-1996.
• Long-term effects of a community-based intervention: 5-year follow-up of 'Clubs against Drugs'. Abdon J.G., Wallin E., Andreasson S., p. 1997-2004.
• Planned quit attempts among Ontario smokers: impact on abstinence. Sendzik T., McDonald P.W., Brown K.S., Hammond D., Ferrence R., p. 2005-2013.
• What do we know about unplanned quit attempts? Practically nothing or nothing practical? Prochaska J.O., p. 2014-2015.
• A response to prochaska: life does not always go according to plan; your quitting might not either. Sendzik T., McDonald P.W., Brown K.S., Hammond D., Ferrence R., p. 2015-2016.
• Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Etter J.F., Bullen C., p. 2017-2028.
• Commentary on Etter & Bullen (2011): Could E-cigs become the ultimate nicotine maintenance device? Foulds J., Veldheer S., p. 2029-2030.
• The timing of smoking onset, prolonged abstinence and relapse in men: a prospective study from ages 18 to 32 years. Kerr D.C., Owen L.D., Capaldi D.M., p. 2031-2038.
• Statistical analysis of daily smoking status in smoking cessation clinical trials. Li Y., Wileyto E.P., Heitjan D.F., p. 2039-2046.
• Reversing the taxes approach for a win-win tobacco control policy. Braillon A., p. 2047.
• Equity considerations in the calculation of cost-effectiveness in substance use disorder populations. Gilmour S.J., p. 2047-2048.
• Editorial: Russia and human immunodeficiency virus- beyond crime and punishment. Samet J.H., p. 1883-1885.
• FOR DEBATE: Basing drug scheduling decisions on scientific ranking of harmfulness: false promise from false premises. Caulkins J.P., Reuter P., Coulson C., p. 1886-1890.
COMMENTARIES:
• Nutt et al.'s harm scales for drugs-room for improvement but better policy based on science with limitations than no science at all. Fischer B., Kendall P., p. 1891-1892.
• Let not the best be the enemy of the good. Nutt D., p. 1892-1893.
• Can harm ratings be useful? Rossow I., p. 1893-1894.
• Improved ranking of drugs on harmfulness can bring sense and order to a failed system. Obot I.S., p. 1894-1895.
• Scales and blinkers, motes and beams - whose view is obstructed on drug scheduling? Room R., p. 1895-1896.
• Response to commentaries. Caulkins J.P., Reuter P., Coulson C., p. 1896-1898.
• What can we learn from the Dutch cannabis coffeeshop system? Maccoun R.J., p. 1899-1910.
• A systematic review of methamphetamine precursor regulations. McKetin R., Sutherland R., Bright D.A., Norberg M.M., p. 1911-1924.
• Housewife or working mum-each to her own? The relevance of societal factors in the association between social roles and alcohol use among mothers in 16 industrialized countries. Kuntsche S., Knibbe R.A., Kuntsche E., Gmel G., p. 1925-1932.
• Commentary on Kuntsche et al. (2011): Mothers and bottles - the role of gender norms in shaping drinking. Armstrong E.M., p. 1933-1934.
• DSM-IV to DSM-5: the impact of proposed revisions on diagnosis of alcohol use disorders. Agrawal A., Heath A.C., Lynskey M.T., p. 1935-1943.
• Commentary on Agrawal et al. (2011): Assessing the impact of changes to diagnostic criteria on the estimated prevalence of alcohol use disorders in general population surveys. Slade T., Teesson M., Carragher N., Farrell M., p. 1944-1945.
• Drinking behaviour among men and women in China: the 2007 China Chronic Disease and Risk Factor Surveillance. Li Y., Jiang Y., Zhang M., Yin P., Wu F., Zhao W., p. 1946-1956.
• The role of alcohol in the Russian mortality crisis. Norstrom T., p. 1957-1965.
• The effect of neighborhood deprivation and residential relocation on long-term injection cessation among injection drug users (IDUs) in Baltimore, Maryland. Genberg B.L., Gange S.J., Go V.F., Celentano D.D., Kirk G.D., Latkin C.A., et al., p. 1966-1974.
• Commentary on Genberg et al. (2011): The structural vulnerability imposed by hypersegregated US inner-city neighborhoods - a theoretical and practical challenge for substance abuse research. Bourgois P., Hart L.K., p. 1975-1977.
• The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Turner K.M., Hutchinson S., Vickerman P., Hope V., Craine N., Palmateer N., et al., p. 1978-1988.
• Commentary on Turner et al. (2011): Significant global scale-up of harm reduction interventions and pragmatic research approaches needed to prevent hepatitis C transmission. Day C., Topp L., p. 1989-1990.
• Mephedrone: use, subjective effects and health risks. Winstock A., Mitcheson L., Ramsey J., Davies S., Puchnarewicz M., Marsden J., p. 1991-1996.
• Long-term effects of a community-based intervention: 5-year follow-up of 'Clubs against Drugs'. Abdon J.G., Wallin E., Andreasson S., p. 1997-2004.
• Planned quit attempts among Ontario smokers: impact on abstinence. Sendzik T., McDonald P.W., Brown K.S., Hammond D., Ferrence R., p. 2005-2013.
• What do we know about unplanned quit attempts? Practically nothing or nothing practical? Prochaska J.O., p. 2014-2015.
• A response to prochaska: life does not always go according to plan; your quitting might not either. Sendzik T., McDonald P.W., Brown K.S., Hammond D., Ferrence R., p. 2015-2016.
• Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Etter J.F., Bullen C., p. 2017-2028.
• Commentary on Etter & Bullen (2011): Could E-cigs become the ultimate nicotine maintenance device? Foulds J., Veldheer S., p. 2029-2030.
• The timing of smoking onset, prolonged abstinence and relapse in men: a prospective study from ages 18 to 32 years. Kerr D.C., Owen L.D., Capaldi D.M., p. 2031-2038.
• Statistical analysis of daily smoking status in smoking cessation clinical trials. Li Y., Wileyto E.P., Heitjan D.F., p. 2039-2046.
• Reversing the taxes approach for a win-win tobacco control policy. Braillon A., p. 2047.
• Equity considerations in the calculation of cost-effectiveness in substance use disorder populations. Gilmour S.J., p. 2047-2048.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
J. P. CAULKINS ;
P. REUTER ;
C. COULSON
|
2011
Dans Addiction (Vol.106, n°11, November 2011) Article : Périodique
Dans Addiction (Vol.106, n°11, November 2011) Article : Périodique
In recent years a number of studies have attempted to rank drugs by a single measure of harmfulness as the basis for decisions about scheduling and classification. These efforts are fundamentally flawed, both conceptually and methodologically. T[...]
AIMS To examine the empirical consequences of officially tolerated retail sales of cannabis in the Netherlands, and possible implications for the legalization debate.
METHODS Available Dutch data on the prevalence and patterns of use, treatmen[...]
R. McKETIN ;
R. SUTHERLAND ;
D. A. BRIGHT ;
M. M. NORBERG
|
2011
Dans Addiction (Vol.106, n°11, November 2011) Article : Périodique
Dans Addiction (Vol.106, n°11, November 2011) Article : Périodique
AIMS To assess the effectiveness of methamphetamine precursor regulations in reducing illicit methamphetamine supply and use.
METHODS A systematic review of 12 databases was used to identify studies that had evaluated the impact of methampheta[...]
K. M. E. TURNER ;
S. HUTCHINSON ;
P. VICKERMAN ;
V. HOPE ;
N. CRAINE ;
N. E. PALMATEER ;
M. MAY ;
A. TAYLOR ;
D. DE ANGELIS ;
S. CAMERON ;
J. PARRY ;
M. LYONS ;
D. GOLDBERG ;
E. ALLEN ;
M. HICKMAN
|
2011
Dans Addiction (Vol.106, n°11, November 2011) Article : Périodique
Dans Addiction (Vol.106, n°11, November 2011) Article : Périodique
AIMS To investigate whether opiate substitution therapy (OST) and needle and syringe programmes (NSP) can reduce hepatitis C virus (HCV) transmission among injecting drug users (IDUs).
DESIGN Meta-analysis and pooled analysis, with logistic re[...]
A. WINSTOCK ;
L. MITCHESON ;
J. RAMSEY ;
S. DAVIES ;
M. PUCHNAREWICZ ;
J. MARSDEN
|
2011
Dans Addiction (Vol.106, n°11, November 2011) Article : Périodique
Dans Addiction (Vol.106, n°11, November 2011) Article : Périodique
AIMS To assess the patterns of use, subjective effect profile and dependence liability of mephedrone, supported by corroborative urine toxicology.
DESIGN Cross-sectional structured telephone interview. Setting UK-based drug users associated wi[...]